Trials / Unknown
UnknownNCT05871515
3D Ultrasound of Abdominal Aortic Aneurysm Characteristics
3D Ultrasound of Abdominal Aortic Aneurysm Characteristics for Predicting Aneurysm Shrinkage After Endovascular Repair
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Rijnstate Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
AAA characteristics are traditionally measured with computed tomography angiography (CTA), however, three-dimensional ultrasound (3D US) is emerging as a novel imaging method for AAAs. With the use of a US contrast agent, the AAA thrombus can also be distinguished from the lumen on the 3D scans. This enables 3D visualization of the AAA and its thrombus without the need for harmful radiation and nephrotoxic contrast agents, as opposed to CTA. In in vitro measurements, 3D US has already been shown to have clinically acceptable error rate with AAA diameter and volume measurement. However, it is unclear whether this is also applicable to in vivo measurements. Therefore, the aim of this prospective study is to compare preoperative 3D US AAA characteristics as measured by 3D US with contrast enhancement (3D CEUS), 3D US without contrast enhancement (3D non-CEUS) and CTA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D ultrasound | A 3D ultrasound is performed preoperatively to measure various aneurysm characteristics |
Timeline
- Start date
- 2022-12-27
- Primary completion
- 2023-12-13
- Completion
- 2025-01-01
- First posted
- 2023-05-23
- Last updated
- 2024-02-01
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05871515. Inclusion in this directory is not an endorsement.